André Goerke

Leniobio GmbH is a German protein expression platform company that focuses on the discovery, development, and large-scale production of proteins. The company was established in September 2016 and has offices in Dusseldorf and R&D and production labs in Aachen. Leniobio is redefining biopharma manufacturing and believes in providing equal opportunities for everyone to lead a healthy life. The company was founded by Remberto Martis, and André Goerke has been the CEO since 2023.

Leniobio GmbH is a German protein expression platform company that focuses on the discovery, development, and large-scale production of proteins. The company was established in September 2016 and has offices in Dusseldorf and R&D and production labs in Aachen. Leniobio is redefining biopharma manufacturing and believes in providing equal opportunities for everyone to lead a healthy life. The company was founded by Remberto Martis, and André Goerke has been the CEO since 2023.

Leniobio GmbH is a German protein expression platform company that focuses on the discovery, development, and large-scale production of proteins. The company was established in September 2016 and has offices in Dusseldorf and R&D and production labs in Aachen. Leniobio is redefining biopharma manufacturing and believes in providing equal opportunities for everyone to lead a healthy life. The company was founded by Remberto Martis, and André Goerke has been the CEO since 2023.

Leniobio GmbH is a German protein expression platform company that focuses on the discovery, development, and large-scale production of proteins. The company was established in September 2016 and has offices in Dusseldorf and R&D and production labs in Aachen. Leniobio is redefining biopharma manufacturing and believes in providing equal opportunities for everyone to lead a healthy life. The company was founded by Remberto Martis, and André Goerke has been the CEO since 2023.